Nuclera joins Tech Nation’s Future Fifty program

Nuclera recognized as one of UK’s most exciting growth stage companies.

Device component-maker Zeus exploring sale: Reuters

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Zeus, a privately held manufacturer

September 27, 2023

Amino Acid Derivative Fails to Eliminate TB Infection in Mid-Stage Trial

N-acetylcysteine (NAC) failed to eradicate Mycobacterium tuberculosis infection, but it did appear to improve lung function in patients with moderate or far-advanced disease, according to

August 29, 2024

Tech in Diabetes: What’s Going Wrong?

ORLANDO — Technologic advances aren’t fulfilling their promise for improving diabetes or overall health outcomes in the U.S., argued FDA Commissioner Robert Califf, MD. “We

June 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.